TY - JOUR
T1 - Single-Cell Transcriptomics Reveal Disrupted Kidney Filter Cell-Cell Interactions after Early and Selective Podocyte Injury
AU - Clark, Abbe R.
AU - Marshall, Jamie
AU - Zhou, Yiming
AU - Montesinos, Monica S.
AU - Chen, Haiqi
AU - Nguyen, Lan
AU - Chen, Fei
AU - Greka, Anna
N1 - Funding Information:
Supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases grants DK103658, DK099465, and DK095045 (A.G.). Disclosures: A.G. has a financial interest in Goldfinch Biopharma, which was reviewed and is managed by Brigham and Women's Hospital and Partners HealthCare and the Broad Institute of MIT and Harvard in accordance with their conflict of interest policies.
Funding Information:
Supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases grants DK103658 , DK099465 , and DK095045 (A.G.).
Publisher Copyright:
© 2022 American Society for Investigative Pathology
PY - 2022/2
Y1 - 2022/2
N2 - The health of the kidney filtration barrier requires communication among podocytes, endothelial cells, and mesangial cells. Disruption of these cell-cell interactions is thought to contribute to disease progression in chronic kidney diseases (CKDs). Podocyte ablation via doxycycline-inducible deletion of an essential endogenous molecule, CTCF [inducible podocyte-specific CTCF deletion (iCTCFpod−/−)], is sufficient to drive progressive CKD. However, the earliest events connecting podocyte injury to disrupted intercellular communication within the kidney filter remain unclear. Single-cell RNA sequencing of kidney tissue from iCTCFpod−/− mice after 1 week of doxycycline induction was performed to generate a map of the earliest transcriptional effects of podocyte injury on cell-cell interactions at single-cell resolution. A subset of podocytes had the earliest signs of injury due to disrupted gene programs for cytoskeletal regulation and mitochondrial function. Surviving podocytes up-regulated collagen type IV ɑ5, causing reactive changes in integrin expression in endothelial populations and mesangial cells. Intercellular interaction analysis revealed several receptor-ligand-target gene programs as drivers of endothelial cell injury and abnormal matrix deposition. This analysis reveals the earliest disruptive changes within the kidney filter, pointing to new, actionable targets within a therapeutic window that may allow us to maximize the success of much needed therapeutic interventions for CKDs.
AB - The health of the kidney filtration barrier requires communication among podocytes, endothelial cells, and mesangial cells. Disruption of these cell-cell interactions is thought to contribute to disease progression in chronic kidney diseases (CKDs). Podocyte ablation via doxycycline-inducible deletion of an essential endogenous molecule, CTCF [inducible podocyte-specific CTCF deletion (iCTCFpod−/−)], is sufficient to drive progressive CKD. However, the earliest events connecting podocyte injury to disrupted intercellular communication within the kidney filter remain unclear. Single-cell RNA sequencing of kidney tissue from iCTCFpod−/− mice after 1 week of doxycycline induction was performed to generate a map of the earliest transcriptional effects of podocyte injury on cell-cell interactions at single-cell resolution. A subset of podocytes had the earliest signs of injury due to disrupted gene programs for cytoskeletal regulation and mitochondrial function. Surviving podocytes up-regulated collagen type IV ɑ5, causing reactive changes in integrin expression in endothelial populations and mesangial cells. Intercellular interaction analysis revealed several receptor-ligand-target gene programs as drivers of endothelial cell injury and abnormal matrix deposition. This analysis reveals the earliest disruptive changes within the kidney filter, pointing to new, actionable targets within a therapeutic window that may allow us to maximize the success of much needed therapeutic interventions for CKDs.
UR - http://www.scopus.com/inward/record.url?scp=85124224102&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124224102&partnerID=8YFLogxK
U2 - 10.1016/j.ajpath.2021.11.004
DO - 10.1016/j.ajpath.2021.11.004
M3 - Article
C2 - 34861215
AN - SCOPUS:85124224102
SN - 0002-9440
VL - 192
SP - 281
EP - 294
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 2
ER -